ETC Group Briefing for CBD COP 10 in Nagoya: Synthetic Biology
Enviado por ETC Staff el
As the Conference of the Parties (COP) to the Convention on Biological Diversity (CBD) ponders guidelines for considering new and emerging issues that may have implications for biodiversity – and struggles to adopt a protocol on access and benefit sharing (ABS) – researchers in synthetic biology are developing the capacity to construct synthetic life forms. The repercussions for biological diversity are unknown but could be devastating. Natural organisms, too, may be “tweaked” using synthetic biology to allow for patent monopolies beyond the reach of state sovereignty or of indigenous peoples.



